Leigh Brody, chief scientific officer, Desktop Genetics
Leigh is a recovering academic with a BSc in biochemistry from Simmons College and a PhD from Imperial College London.
While completing her doctorate, she developed nanoparticles to facilitate small molecule delivery for oncology and metabolic syndrome. One of these nanoparticles was spun out into a company where she served as Head of Preclinical Development.
Leigh also worked at Index Ventures on the life sciences team focusing on early-stage investments. Prior to that, Leigh worked at the Broad Institute in the RNAi Consortium (TRC) as part of TRC 1, 2 and Project Achilles.
After making the leap from RNAi to CRISPR, Leigh now facilitates collaborations with academia, biotech and pharma by planning multiplex CRISPR experiments at Desktop Genetics.
Leigh is an avid traveler for work and play. She also enjoys long distance running, cooking, snowboarding and volunteering in STEM.